|
||
BRIEF DEFINITIVE REPORT |
CORRESPONDENCE Markus Mohrs: mmohrs{at}trudeauinstitute.org
|
|
|---|
IL-4 is widely recognized as the canonical marker for Th2-polarized CD4+ T cells (1). IL-4 was originally identified by its function as a B cell–stimulating factor (2, 3), and numerous in vivo models of infection concur that IL-4 is critical for the isotype switch of B cells to IgE and IgG1 (4–10). IL-4 also promotes the Th2 polarization of naive CD4+ T cells in vitro (11, 12). However, in vivo studies have found that Th2 cells can develop in mice deficient for IL-4, the IL-4R
T follicular helper (Tfh) cells are a subset of CD4+ T cells that migrate to B cell follicles after activation and promote germinal center formation and B cell Ig isotype switching in mice and humans (13–16). Phenotypically, Tfh cells are characterized by expression of CXCR5 (an obligatory receptor for the follicle-homing chemokine CXCL13) (17), the inducible co-stimulatory receptor ICOS (18, 19), and the inhibitory receptors PD-1 (also known as CD279) (14) and B and T lymphocyte attenuator (BTLA) (13). A previous study (13) using model antigens in adjuvant have suggested that Tfh cells are a distinct lineage of T helper cells that arises independently of Th1, Th2, and Th17 effector subsets. To date, however, no studies have examined the Tfh response during infection with a Th2-polarizing pathogen. To unambiguously identify and localize Th2 cells and IL-4 production in the reactive lymph nodes in vivo, we infected IL-4 dual reporter mice (20), in which cells that express IL-4 are marked by GFP and IL-4–producing subsets additionally display surface huCD2, with the mouse gastrointestinal helminth parasite Heligmosomoides polygyrus. We find that IL-4–producing Th2 cells localize to the B cell follicles and exhibit a Tfh cell phenotype in the draining lymph nodes of infected animals. In addition, we find that although IL-4 is dispensable for the generation of Tfh cells, it is critical for a mature B cell response. To our knowledge, this is the first report to show the location of IL-4–producing T cells in the reactive lymph nodes after helminth infection. Furthermore, our results challenge the prevailing concept that Tfh cells are a distinct T helper lineage. Rather, we suggest that Tfh cells act to support the demands of the impending immune response.
chain, or the IL-4R–associated Stat 6 (4–8). Collectively, these observations suggest that IL-4 production in sentinel lymph nodes draining a site of infection may be more important to support type 2 B cell responses rather than to establish the underlying Th2 response. Therefore, it stands to reason that the production of IL-4 by Th2 cells should preferentially occur in B cell follicles to optimize B cell help. However, the localization and characterization of IL-4–producing T cells in the lymph nodes has not been assessed.
![]()
RESULTS AND DISCUSSION
Top
ABSTRACT
RESULTS AND DISCUSSION
MATERIALS AND METHODS
REFERENCES
IL-4–producing Th2 cells are restricted to the B cell follicle and associate with germinal centers
Using direct ex vivo analysis of IL-4 dual reporter (4get/KN2) mice, we have previously shown that IL-4–producing/huCD2+ cells represent only a subset of IL-4–expressing/GFP+ Th2 cells in the draining mesenteric lymph nodes (mesLNs) of H. polygyrus–infected mice (20). Although IL-4–producing Th2 cells displayed some phenotypic and functional differences compared with GFP+huCD2– cells, we did not assess whether they additionally differed with respect to their localization within the lymph nodes. To explore this issue, we infected 4get/KN2 mice with H. polygyrus and 2 wk later performed immunohistochemistry on mesLN sections to identify huCD2+ cells in spatial relationship to T cell zones, B cell follicles, and germinal centers. As shown in Fig. 1 (A and B), CD4+huCD2+ cells were almost exclusively found in B cell follicles, whereas they were rarely detected in T cell areas. Additional staining with peanut agglutinin (PNA) revealed that CD4+huCD2+ cells were generally associated with germinal centers within the B cell follicle (Fig. 1 C). In contrast, CD4+GFP+ T cells that had initiated the expression of IL-4 (5) were detected throughout the lymph nodes and were not, unlike huCD2+ cells, preferentially found in the B cell follicle (Fig. 1, D and E). These data show that the huCD2+/IL-4–producing subset within the GFP+ Th2 population is highly enriched in B cell follicles and germinal centers.
|
|
|
|
–deficient 4get mice with H. polygyrus and characterized B cell maturation and the germinal center response in the mesLNs. Of note, because T and B cells do not respond to IL-13 (24, 25), IL-4R
–deficient mice functionally recapitulate IL-4–deficient animals with respect to these subsets while allowing for analysis of the IL-4/GFP response. Consistent with Fig. 4 and previous studies (4, 5), IL-4R
–/– mice mounted a robust Th2 response within the first week of infection, as indicated by the substantial increase in the number of CD4+GFP+ cells (Fig. 5 A). Interestingly, this Th2 response was not maintained during the second week of infection in the absence of IL-4R–mediated functions. The analysis of the accompanying B cell response revealed that although the number of B cells in naive mice was comparable between WT and IL-4R
–/– animals, it was strikingly reduced in IL-4R
–/– mice 2 wk after infection (Fig. 5 B). Notably, this defect was not apparent 1 wk after infection, a time point at which Tfh cells begin to differentiate and populate the B cell follicle (Fig. 3). Moreover, the B cell population in IL-4R
–deficient animals was significantly impaired in the up-regulation of MHC class II (I-Ad), the co-stimulatory molecule CD86, and the low affinity IgE receptor, CD23 (Fig. 5 C). Despite the presence of Tfh cells in the absence of IL-4 function (Fig. 4 A), there was a striking defect in the formation of germinal centers as identified by staining of CD19+ B cells for PNA and Fas (Fig. 5 D). Lastly, consistent with the severely compromised IgG1 and IgE antibody response previously reported in IL-4R
– and IL-4–deficient mice (unpublished data) (6, 7, 9, 10, 25), the frequency of IgG1+/IgD– B cells was substantially decreased (Fig. 5 E) and serum IgE was undetectable (not depicted). These data show that IL-4–mediated functions, but not the mere presence of Tfh cells per se, are critical to orchestrate multiple features of an appropriately matured B cell response after helminth infection.
|
In contrast to IL-4–producing cells, IL-4–competent T cells expressing GFP were widespread throughout the lymph nodes (Fig. 1). As we have previously shown, this subset can rapidly induce huCD2 expression upon stimulation (20). Furthermore, a high frequency of GFP+huCD2+ Th2 cells are present in effector sites after H. polygyrus infection, such as the lamina propria of the small intestine (20). Interestingly, Zaretsky et al. show that huCD2+ cells in nonlymphoid effector sites do not display characteristics of Tfh cells (see Zaretsky et al. [26] on p. 991 of this issue). They also demonstrate the ability of IL-4–competent T cells to differentiate into Tfh cells in a germinal center–dependent manner after transfer into mice immunized with schistosome egg antigen (26). Collectively, these observations suggest that IL-4–competent cells within the T cell zone represent a pluripotent lineage of Th2 cells that must cross a critical checkpoint before progressing to an effector subset either within the lymph nodes or peripheral tissue. Whether this process is regulated by reencounter with antigen and/or alternative signals remains to be determined (23, 27).
In addition to the investigation into the localization of IL-4 production within the reactive lymph nodes, our report challenges the notion recently put forth by Nurieva et al. that Tfh cells develop independently from Th1, Th2, or Th17 cells (28). Indeed, it is clear from our and other studies that IL-4 is dispensable for Tfh generation (Fig. 4) (28). However, our data also indicate that IL-4 is important for maintaining the expansion and/or accumulation of Th2 and B cells over the course of a chronic infection. Nevertheless, in the context of an infection that elicits robust Th2 responses, we show that Tfh cells are the dominant if not exclusive IL-4–producing cells in the reactive lymph nodes and that IL-4 serves as a critical effector cytokine for a mature B cell response. Given the number of experimental settings in which Tfh cells have been shown to be generated, it stands to reason that this lineage of effector cells may withhold the ability to alter its effector phenotype to meet the demands of an appropriate host response (22, 28, 29). Future studies will undoubtedly continue to shed light on the relationship between Tfh cell differentiation and other T helper lineages.
The previously unappreciated compartmentalization of Th2 cell differentiation versus IL-4 production in the reactive lymph nodes represents an important advancement in our understanding of the two-step process for cytokine production we have previously described (20). The extent and timing of the B cell defects observed in IL-4R
–deficient mice during the second week of infection illustrate how efficiently IL-4–producing Tfh cells populate the B cell follicles throughout the lymph nodes and govern the local environment. The colocalization of IL-4–producing Tfh and B cells is likely to optimize an integrated type 2 response by linking, for example, the IgE isotype switch to the broad up-regulation of CD23, the low affinity IgE receptor, on all B cells. These data in combination with the data from Zaretsky et al. (26) reveal an intricate interdependence between B and T cells in type 2 immunity, with IL-4 as a critical link. Of note, while our manuscript was under consideration, a study by Reinhardt et al. came to similar conclusions using the same IL-4 reporter system in different Th2-polarizing infection models (30). It will be important to determine which signals are provided by B cells in this mutual interaction.
| MATERIALS AND METHODS |
|---|
|
|
|---|
–/– (25), and BALB/c mice were bred and kept under specific pathogen-free conditions at the Trudeau Institute, and were used at 8–12 wk of age. Animals were infected by gavage with 200 third-stage larvae of H. polygyrus, as previously described (20). All experiments were performed under Trudeau Institute Institutional Animal Care and Use Committee–approved protocols.
Flow cytometry.
Single-cell suspensions were prepared from the mesLNs, stained and analyzed as previously described (20). The following mAbs were used for flow cytometry: CD4-PerCP, CD19-allophycocyanin (APC), hCD2-PE, CXCR5-biotin, Fas-PE, CD23-PE, CD86-PE, and streptavidin-PerCP (BD); I-Ab–biotin and streptavidin-APC (Invitrogen); lectin PNA–biotin (Vector Laboratories); PD-1–PE–Cy7 (BioLegend); IgD–biotin, ICOS-PE, and BTLA-PE (eBioscience); and IgG1-PE (SouthernBiotech). Samples were acquired on a FACSCanto II or FACSCalibur (BD) and were analyzed with FlowJo software (Tree Star, Inc.).
RT-PCR.
cDNA was prepared as previously described (20). TaqMan reagents for GAPDH and IL-4 have been previously described (20), and BCL-6 and IL-21 primers and probes were Assays on Demand purchased from Applied Biosystems. Quantitative real-time RT-PCR was performed by using a TaqMan 7500 Fast System and software (Applied Biosystems). Fold expression was calculated using the 
CT method and GAPDH as a reference gene.
Immunohistochemistry.
mesLNs were harvested from H. polygyrus–infected animals and immediately frozen in optimal cutting temperature (OCT) embedding compound (Sakura Finetek) over liquid nitrogen for detection of surface antigens. To detect intracellular GFP, whole lymph nodes from 4get mice were fixed in a solution of 4% formalin and 10% sucrose for 8 h before freezing. Frozen lymph nodes were cut into 5–8-mm sections on a cryostat (Leica) and fixed in a mixture of ice-cold 75% acetone/25% ethanol for 5 min. Sections were blocked in PBS plus 2% BSA and 5% normal mouse serum for 60 min followed by avidin/biotin blocking solution (Vector Laboratories). Sections were stained with rat anti–mouse B220–Alexa Fluor 488 (clone RA3-6B2) or lectin PNA–Alexa Fluor 488 (Invitrogen), biotin mouse anti–human CD2 (clone RPA-2.10; BioLegend), and CD4-APC (clone RM4-5; eBioscience) in blocking buffer, followed by streptavidin–Alexa Fluor 568 (Invitrogen). All images were captured using a microscope (Axiovert 200M) and analyzed with Axiovision software (both from Carl Zeiss, Inc.), and represent data from three independent experiments.
| Acknowledgments |
|---|
This work was supported by funds from the Trudeau Institute and the National Institutes of Health (grants AI072296 and AI076479 to M. Mohrs). I.L. King is the recipient of a T32 training award (AI049823).
The authors have no conflicting financial interests.
Submitted: 10 February 2009
Accepted: 1 April 2009
| REFERENCES |
|---|
|
|
|---|
Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787–793.[CrossRef][Medline]
Howard, M., J. Farrar, M. Hilfiker, B. Johnson, K. Takatsu, T. Hamaoka, and W.E. Paul. 1982. Identification of a T cell–derived b cell growth factor distinct from interleukin 2. J. Exp. Med. 155:914–923.
Vitetta, E.S., J. Ohara, C.D. Myers, J.E. Layton, P.H. Krammer, and W.E. Paul. 1985. Serological, biochemical, and functional identity of B cell–stimulatory factor 1 and B cell differentiation factor for IgG1. J. Exp. Med. 162:1726–1731.
Mohrs, M., C. Holscher, and F. Brombacher. 2000. Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection. Infect. Immun. 68:1773–1780.
Mohrs, M., K. Shinkai, K. Mohrs, and R.M. Locksley. 2001. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity. 15:303–311.[CrossRef][Medline]
Jankovic, D., M.C. Kullberg, N. Noben-Trauth, P. Caspar, W.E. Paul, and A. Sher. 2000. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile. J. Immunol. 164:3047–3055.
Noben-Trauth, N., L.D. Shultz, F. Brombacher, J.F. Urban, Jr., H. Gu, and W.E. Paul. 1997. An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA. 94:10838–10843.
van Panhuys, N., S.C. Tang, M. Prout, M. Camberis, D. Scarlett, J. Roberts, J. Hu-Li, W.E. Paul, and G. Le Gros. 2008. In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation. Proc. Natl. Acad. Sci. USA. 105:12423–12428.
Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science. 254:707–710.
Kopf, M., G. Le Gros, M. Bachmann, M.C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 362:245–248.[CrossRef][Medline]
Le Gros, G., S.Z. Ben-Sasson, R. Seder, F.D. Finkelman, and W.E. Paul. 1990. Generation of interleukin 4 (IL-4)–producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4–producing cells. J. Exp. Med. 172:921–929.
Swain, S.L., A.D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796–3806.[Abstract]
King, C., S.G. Tangye, and C.R. Mackay. 2008. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 26:741–766.[CrossRef][Medline]
Haynes, N.M., C.D. Allen, R. Lesley, K.M. Ansel, N. Killeen, and J.G. Cyster. 2007. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J. Immunol. 179:5099–5108.
Schaerli, P., K. Willimann, A.B. Lang, M. Lipp, P. Loetscher, and B. Moser. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192:1553–1562.
Breitfeld, D., L. Ohl, E. Kremmer, J. Ellwart, F. Sallusto, M. Lipp, and R. Forster. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192:1545–1552.
Gunn, M.D., V.N. Ngo, K.M. Ansel, E.H. Ekland, J.G. Cyster, and L.T. Williams. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitts lymphoma receptor-1. Nature. 391:799–803.[CrossRef][Medline]
Bossaller, L., J. Burger, R. Draeger, B. Grimbacher, R. Knoth, A. Plebani, A. Durandy, U. Baumann, M. Schlesier, A.A. Welcher, et al. 2006. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J. Immunol. 177:4927–4932.
Akiba, H., K. Takeda, Y. Kojima, Y. Usui, N. Harada, T. Yamazaki, J. Ma, K. Tezuka, H. Yagita, and K. Okumura. 2005. The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J. Immunol. 175:2340–2348.
Mohrs, K., A.E. Wakil, N. Killeen, R.M. Locksley, and M. Mohrs. 2005. A two-step process for cytokine production revealed by IL-4 dual-reporter mice. Immunity. 23:419–429.[CrossRef][Medline]
Mohrs, K., D.P. Harris, F.E. Lund, and M. Mohrs. 2005. Systemic dissemination and persistence of th2 and type 2 cells in response to infection with a strictly enteric nematode parasite. J. Immunol. 175:5306–5313.
Vogelzang, A., H.M. McGuire, D. Yu, J. Sprent, C.R. Mackay, and C. King. 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity. 29:127–137.[CrossRef][Medline]
Garside, P., E. Ingulli, R.R. Merica, J.G. Johnson, R.J. Noelle, and M.K. Jenkins. 1998. Visualization of specific B and T lymphocyte interactions in the lymph node. Science. 281:96–99.
Nelms, K., A.D. Keegan, J. Zamorano, J.J. Ryan, and W.E. Paul. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17:701–738.[CrossRef][Medline]
Mohrs, M., B. Ledermann, G. Köhler, A. Dorfmüller, A. Gessner, and F. Brombacher. 1999. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J. Immunol. 162:7302–7308.
Zaretsky, A.G., J.J. Taylor, I.L. King, F.A. Marshall, M. Mohrs, and E.J. Pearce. 2009. T follicular helper cells differentiate from Th2 cells in response to helminth antigens. J. Exp. Med. 206:991–999.
Jenkins, M.K., A. Khoruts, E. Ingulli, D.L. Mueller, S.J. McSorley, R.L. Reinhardt, A. Itano, and K.A. Pape. 2001. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19:23–45.[CrossRef][Medline]
Nurieva, R.I., Y. Chung, D. Hwang, X.O. Yang, H.S. Kang, L. Ma, Y.H. Wang, S.S. Watowich, A.M. Jetten, Q. Tian, and C. Dong. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity. 29:138–149.[CrossRef][Medline]
Bauquet, A.T., H. Jin, A.M. Paterson, M. Mitsdoerffer, I.C. Ho, A.H. Sharpe, and V.K. Kuchroo. 2009. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10:167–175.[CrossRef][Medline]
Reinhardt, R.L., H.E. Liang, and R.M. Locksley. 2009. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 10:385–393.[CrossRef][Medline]
Related Articles
Related In this Issue article
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|